A detailed history of Eulav Asset Management transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Eulav Asset Management holds 29,402 shares of TMO stock, worth $15.2 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares
29,402
Previous 29,400 0.01%
Holding current value
$15.2 Million
Previous $16.3 Million 11.86%
% of portfolio
0.44%
Previous 0.44%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$531.86 - $624.21 $1,063 - $1,248
2 Added 0.01%
29,402 $18.2 Million
Q1 2024

May 30, 2024

SELL
$528.82 - $599.43 $1,586 - $1,798
-3 Reduced 0.01%
29,400 $17.1 Million
Q4 2023

Feb 14, 2024

SELL
$431.41 - $532.94 $16.8 Million - $20.7 Million
-38,923 Reduced 56.97%
29,403 $15.6 Million
Q1 2023

Apr 27, 2023

SELL
$535.0 - $604.82 $16.4 Million - $18.6 Million
-30,674 Reduced 30.98%
68,326 $39.4 Million
Q4 2022

Feb 14, 2023

SELL
$484.71 - $571.37 $1.94 Million - $2.29 Million
-4,000 Reduced 3.88%
99,000 $54.5 Million
Q2 2022

Jul 22, 2022

SELL
$500.9 - $612.21 $14.5 Million - $17.8 Million
-29,000 Reduced 21.97%
103,000 $56 Million
Q4 2021

Feb 11, 2022

SELL
$569.0 - $667.24 $125,180 - $146,792
-220 Reduced 0.17%
132,000 $88.1 Million
Q3 2021

Nov 15, 2021

SELL
$509.53 - $609.78 $3,057 - $3,658
-6 Reduced -0.0%
132,220 $75.5 Million
Q2 2021

Aug 06, 2021

SELL
$441.0 - $508.24 $882 - $1,016
-2 Reduced -0.0%
132,226 $66.7 Million
Q1 2021

Apr 30, 2021

SELL
$439.85 - $518.83 $2.2 Million - $2.59 Million
-5,000 Reduced 3.64%
132,228 $60.3 Million
Q4 2020

Feb 16, 2021

BUY
$435.06 - $527.66 $12,181 - $14,774
28 Added 0.02%
137,228 $63.9 Million
Q3 2020

Nov 05, 2020

SELL
$359.77 - $441.52 $12,951 - $15,894
-36 Reduced 0.03%
137,200 $60.6 Million
Q2 2020

Aug 11, 2020

BUY
$275.2 - $362.34 $9,907 - $13,044
36 Added 0.03%
137,236 $49.7 Million
Q1 2020

Apr 27, 2020

BUY
$255.3 - $340.05 $4.34 Million - $5.78 Million
17,000 Added 14.14%
137,200 $38.9 Million
Q4 2019

Feb 13, 2020

BUY
$271.93 - $328.04 $2.61 Million - $3.15 Million
9,600 Added 8.68%
120,200 $39 Million
Q3 2019

Nov 12, 2019

BUY
$268.46 - $305.43 $10.6 Million - $12.1 Million
39,500 Added 55.56%
110,600 $32.2 Million
Q2 2019

Aug 05, 2019

BUY
$257.51 - $295.55 $5.79 Million - $6.65 Million
22,500 Added 46.3%
71,100 $20.9 Million
Q1 2019

May 13, 2019

BUY
$212.17 - $273.72 $1.97 Million - $2.55 Million
9,300 Added 23.66%
48,600 $13.4 Million
Q2 2017

Aug 14, 2017

BUY
N/A
39,300
39,300 $6.86 Million

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $202B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Eulav Asset Management Portfolio

Follow Eulav Asset Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eulav Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Eulav Asset Management with notifications on news.